Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol
Authors:
- 1 March 1996
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 41 (3) , 247-249
Abstract
With the future advent of a world wide ban on chlorofluorocarbon containing aerosols, a study was designed to compare the in vivo lung bioavailability of salbutamol via chlorofluorocarbon‐containing metered‐dose inhaler (CFC), chlorofluorocarbon‐free metered‐dose inhaler (CFC‐free), and dry powder inhaler (DPI). Twelve healthy male subjects were given 1200 μg salbutamol and measurements made of plasma and urinary salbutamol. CFC‐free produced significantly higher plasma salbutamol levels (ng ml‐1; mean and 95% CI for difference) than either CFC or DPI: Cmax, CFC‐free 4.18 vs CFC 3.29 (95% CI 0.10–1.68), vs DPI 3.42 (95% CI ‐0.03–1.56). The ratio for the difference in Cmax between CFC and CFC‐free formulations was 1.32 (95% CI 1.02–1.61). There were no significant differences between CFC and DPI formulations. Urinary salbutamol results did not reveal any significant differences between the three inhalers (μg 30 min‐1): CFC‐free 42.4, CFC 43.8, DPI 45.3. Thus, the lung bioavailibility of CFC‐free was greater than that of CFC or DPI formulations of salbutamol.Keywords
This publication has 7 references indexed in Scilit:
- Metered-dose inhalers and CFCs: what respiratory physicians need to knowRespiratory Medicine, 1994
- Comparison of the extrapulmonary β2‐adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose‐inhaler and modified actuator deviceBritish Journal of Clinical Pharmacology, 1993
- Bronchodilator Delivery From Gentlehaler, a New Low-Velocity Pressurized Aerosol InhalerChest, 1993
- Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.Thorax, 1993
- Determination of the relative bioavailability of salbutamol to the lung following inhalation [see comments]British Journal of Clinical Pharmacology, 1992
- Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthmaEuropean Journal of Clinical Pharmacology, 1989
- Beta-adrenoceptor responses to inhaled salbutamol in normal subjectsEuropean Journal of Clinical Pharmacology, 1989